BridgeMD
New treatment option for Fibromyalgia (FM)
Official title Effects of a Isokinetic Exercise in Women With Fibromyalgia
ClinicalTrials.gov ID: NCT07483216
What this study is testing
- What it's testing
- Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional impairment, which significantly affects quality of life. Physical exercise is considered one of the most effective non-pharmacological interventions for the management of this condition; however, uncertainty remains regarding the most appropriate type, intensity, and frequency of exercise for different patient profiles.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women aged ≥ 18 years diagnosed with fibromyalgia according to current clinical criteria.
- Clinical and pharmacological stability during the weeks prior to participation in the study.
- Ability to perform supervised exercise and to complete the assessments.
- Written informed consent.
You likely can't join if
- Cardiovascular, neurologic, musculoskeletal or systemic pathology that contraindicate the performance of exercise.
- Significant change in pharmacological treatment during the period immediately preceding the study.
- Any condition that, in clinical judgement, prevents them from following the protocol safely.
The study team makes the final eligibility decision.
Where it's taking place
- Valladolid, Valladolid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valladolid, Valladolid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.